Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8447419 | European Journal of Cancer | 2011 | 7 Pages |
Abstract
Co-morbidity decreased the likelihood of receiving adjuvant radiotherapy in patients with stage I EC qualifying to undergo this according to the Dutch guidelines of 2000. Whereas adjuvant radiotherapy did not seem to affect survival in those patients, co-morbidity significantly did.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
D. Boll, R.H.A. Verhoeven, M.A. van der Aa, M.L.M. Lybeert, J.W.W. Coebergh, M.L.G. Janssen-Heijnen,